UBS Downgrades Baldwin Insurance to Neutral, Lowers Price Target to $32.5

Benzinga · 3d ago
UBS analyst Brian Meredith downgrades Baldwin Insurance (NASDAQ:BWIN) from Buy to Neutral and lowers the price target from $37 to $32.5.